Publications by authors named "Padmanee Sharma"

138 Publications

Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.

Eur Urol Oncol 2020 12 8;3(6):728-738. Epub 2020 Nov 8.

Experimental Cancer Medicine Centre Barts Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital, London, UK.

View Article and Find Full Text PDF
December 2020

Dissecting the mechanisms of immune checkpoint therapy.

Nat Rev Immunol 2020 02;20(2):75-76

Department of Immunology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
February 2020

Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy.

Cell 2019 Nov;179(5):1177-1190.e13

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
November 2019

Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities.

Proc Natl Acad Sci U S A 2019 10 14;116(44):22246-22251. Epub 2019 Oct 14.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030;

View Article and Find Full Text PDF
October 2019

Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.

Cancer Immunol Res 2019 Nov 29;7(11):1803-1812. Epub 2019 Aug 29.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
November 2019